Shanghai Junshi Biosciences Co., Ltd. (SHJBF)
USD 1.24
(0.0%)
USD 1.24
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.01 Billion | -1.77 Billion | -641.9 Million | -1.49 Billion | -1.18 Billion | -510.75 Million |
| Net Income | -2.48 Billion | -2.67 Billion | -592.64 Million | -1.66 Billion | -763.12 Million | -717.56 Million |
| Depreciation & Amortization | 303.22 Million | 293.65 Million | 262.55 Million | 151.36 Million | 59.59 Million | 30.2 Million |
| Deferred income taxes | - | -20.82 Million | -9.64 Million | -800.42 Thousand | -2.8 Million | -173.74 Thousand |
| Stock-based compensation | 22.98 Million | 91.91 Million | 192.75 Million | 30.72 Million | 11.79 Million | 21.7 Million |
| Change in working capital | -80.87 Million | 687.18 Million | -318.77 Million | -13.06 Million | -464.06 Million | 126.68 Million |
| Other non-cash items | -104.4 Million | -152.05 Million | -176.14 Million | 2.43 Million | -28.42 Million | 28.39 Million |
| Investing Cash Flow | -892.42 Million | -467.61 Million | -1.88 Billion | -697.97 Million | -952.03 Million | -420.98 Million |
| Investments in PPE | -832.57 Million | -393.95 Million | -886.22 Million | -592.68 Million | -863.14 Million | -557.37 Million |
| Acquisitions | -19.34 Million | -93.78 Million | -440.08 Million | 2.9 Million | -73.74 Million | 1.25 Million |
| Investment purchases | -1.39 Billion | -8.48 Million | -1.16 Billion | -245.16 Million | -117.34 Million | -403.5 Million |
| Sales/Maturities of investments | 1.21 Billion | 13.54 Million | 565.28 Million | 70.13 Million | 72.2 Million | 513.77 Million |
| Other Investing Activities | 40.38 Million | 15.05 Million | 49.69 Million | 66.83 Million | 30.01 Million | 24.86 Million |
| Financing Cash Flow | 681.04 Million | 4.64 Billion | 2.66 Billion | 4.41 Billion | 593.58 Million | 3.43 Billion |
| Debt repayment | -496.18 Million | -113.44 Million | -793.33 Million | -401.41 Million | -1.38 Billion | -106 Million |
| Dividends payments | -38.22 Million | -19.15 Million | -16.69 Million | -43.15 Million | -58.59 Million | - |
| Common Stock Repurchased | -26.89 Million | - | - | - | - | -1.74 Million |
| Common Stock Issuance | 152.59 Million | 3.81 Billion | 2.15 Billion | 4.84 Billion | 403.83 Million | 3.01 Billion |
| Other Financing Activities | 153 Million | 944.19 Million | 1.3 Billion | -31.99 Million | 1.57 Billion | 585.24 Million |
| Accounts receivables | -314.41 Million | 183.06 Million | -119.08 Million | -69.87 Million | -59.73 Million | -7.85 Million |
| Accounts payables | - | -75.28 Million | 108.54 Million | 99.41 Million | 12.51 Million | 28.72 Million |
| Inventory | -5.06 Million | -136.39 Million | -154.82 Million | -166.98 Million | -132.19 Million | -18.96 Million |
| Other working capital | 19 Million | 715.8 Million | -153.4 Million | 124.38 Million | -284.65 Million | 124.77 Million |
| Cash at beginning of period | 5.99 Billion | 3.5 Billion | 3.38 Billion | 1.21 Billion | 2.76 Billion | 266.29 Million |
| Cash at end of period | 3.77 Billion | 5.99 Billion | 3.5 Billion | 3.38 Billion | 1.21 Billion | 2.76 Billion |
| Capital Expenditure | -832.57 Million | -393.95 Million | -886.22 Million | -592.68 Million | -863.14 Million | -557.37 Million |
| Effect of forex changes on cash | 7.55 Million | 92.26 Million | -23.22 Million | -45.76 Million | -4.06 Million | -3.59 Million |
| Net cash flow / Change in cash | -2.21 Billion | 2.49 Billion | 119.6 Million | 2.17 Billion | -1.54 Billion | 2.49 Billion |
| Free Cash Flow | -2.84 Billion | -2.16 Billion | -1.52 Billion | -2.09 Billion | -2.05 Billion | -1.06 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -39.43 Million | -50.01 Million | -39.33 Million | -121.32 Million | -2.48 Billion | -56.42 Million |
| Depreciation & Amortization | - | 11.41 Million | 11.47 Million | 12.08 Million | 303.22 Million | 12.03 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | 22.98 Million | - |
| Change in working capital | - | - | - | - | -80.87 Million | - |
| Other non-cash items | 902.17 Thousand | -25.02 Million | -13 Million | 100.01 Million | -104.4 Million | -18.33 Million |
| Investing Cash Flow | -17.11 Million | -867.67 Million | -10.18 Million | -52.83 Million | -892.42 Million | -493.61 Million |
| Investments in PPE | -31.93 Million | -183.42 Million | -29.5 Million | -31.64 Million | -832.57 Million | -403.23 Million |
| Acquisitions | 2084.33 | 257.74 Thousand | - | 564.5 Thousand | -19.34 Million | -1.58 Million |
| Investment purchases | -81.25 Million | -739.93 Million | -3.48 Million | -16.69 Million | -1.39 Billion | -110 Million |
| Sales/Maturities of investments | 91.43 Million | -49.61 Million | 20.84 Million | 5.94 Million | 1.21 Billion | 6.79 Million |
| Other Investing Activities | 4.64 Million | -10.45 Million | 1.95 Million | -11 Million | 40.38 Million | 14.41 Million |
| Financing Cash Flow | 22.89 Million | -481.08 Million | 169.54 Million | 37.53 Million | 681.04 Million | 221.07 Million |
| Debt repayment | -26.75 Million | -447.39 Million | -173.44 Million | -39.16 Million | -496.18 Million | -272.55 Million |
| Dividends payments | - | - | -13.64 Million | - | -38.22 Million | - |
| Common Stock Repurchased | - | - | - | - | -26.89 Million | - |
| Common Stock Issuance | 555.47 Thousand | -552.97 Thousand | - | -3.72 Million | 152.59 Million | - |
| Other Financing Activities | -4.41 Million | -3.57 Million | -3.9 Million | 9.4 Million | 153 Million | 493.63 Million |
| Accounts receivables | - | - | - | - | -314.41 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | -5.06 Million | - |
| Other working capital | - | - | - | - | 19 Million | - |
| Cash at beginning of period | 373.04 Million | 4.54 Billion | 533.99 Million | 570.67 Million | 5.99 Billion | 4.85 Billion |
| Cash at end of period | 352.34 Million | 2.71 Billion | 630.72 Million | 533.99 Million | 3.77 Billion | 4.14 Billion |
| Capital Expenditure | -31.93 Million | -183.42 Million | -29.5 Million | -31.64 Million | -832.57 Million | -403.23 Million |
| Effect of forex changes on cash | - | 3.52 Million | 1.24 Million | 12.01 Million | 7.55 Million | -3.56 Million |
| Net cash flow / Change in cash | -20.7 Million | -1.83 Billion | 96.73 Million | -36.68 Million | -2.21 Billion | -712.04 Million |
| Free Cash Flow | -70.47 Million | -247.05 Million | -81.84 Million | -65.04 Million | -2.84 Billion | -465.95 Million |
019170
LSRCF
SINGER
1317
NIITMTS
GLMD